nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP3A7—Paclitaxel—ovarian cancer	0.101	0.111	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.101	0.111	CbGbCtD
Cisapride—CYP3A5—Paclitaxel—ovarian cancer	0.0755	0.0829	CbGbCtD
Cisapride—CYP3A7—Docetaxel—ovarian cancer	0.0728	0.0799	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0728	0.0799	CbGbCtD
Cisapride—CYP2C8—Paclitaxel—ovarian cancer	0.0726	0.0797	CbGbCtD
Cisapride—CYP2D6—Vinorelbine—ovarian cancer	0.0659	0.0724	CbGbCtD
Cisapride—CYP3A4—Topotecan—ovarian cancer	0.0595	0.0653	CbGbCtD
Cisapride—CYP3A5—Docetaxel—ovarian cancer	0.0546	0.0599	CbGbCtD
Cisapride—CYP2B6—Doxorubicin—ovarian cancer	0.0517	0.0567	CbGbCtD
Cisapride—CYP2C9—Paclitaxel—ovarian cancer	0.0507	0.0556	CbGbCtD
Cisapride—CYP3A4—Vinorelbine—ovarian cancer	0.0419	0.046	CbGbCtD
Cisapride—CYP3A4—Paclitaxel—ovarian cancer	0.0295	0.0323	CbGbCtD
Cisapride—CYP2D6—Doxorubicin—ovarian cancer	0.025	0.0274	CbGbCtD
Cisapride—CYP3A4—Docetaxel—ovarian cancer	0.0213	0.0234	CbGbCtD
Cisapride—CYP3A4—Doxorubicin—ovarian cancer	0.0159	0.0174	CbGbCtD
Cisapride—Gefitinib—CHEK2—ovarian cancer	0.00821	0.657	CrCbGaD
Cisapride—HTR2A—vein—ovarian cancer	0.0041	0.118	CbGeAlD
Cisapride—Gefitinib—EGFR—ovarian cancer	0.00328	0.263	CrCbGaD
Cisapride—HTR2B—myometrium—ovarian cancer	0.00151	0.0436	CbGeAlD
Cisapride—KCNH2—myometrium—ovarian cancer	0.0012	0.0347	CbGeAlD
Cisapride—HTR2B—uterine cervix—ovarian cancer	0.00117	0.0339	CbGeAlD
Cisapride—HTR2B—decidua—ovarian cancer	0.00112	0.0323	CbGeAlD
Cisapride—HTR2B—endometrium—ovarian cancer	0.00106	0.0307	CbGeAlD
Cisapride—CYP2A6—vagina—ovarian cancer	0.00104	0.0299	CbGeAlD
Cisapride—Gefitinib—ABCB1—ovarian cancer	0.000997	0.0799	CrCbGaD
Cisapride—HTR2B—uterus—ovarian cancer	0.000979	0.0283	CbGeAlD
Cisapride—KCNH2—uterine cervix—ovarian cancer	0.000937	0.027	CbGeAlD
Cisapride—HTR2C—female reproductive system—ovarian cancer	0.000937	0.027	CbGeAlD
Cisapride—HTR2B—female reproductive system—ovarian cancer	0.00088	0.0254	CbGeAlD
Cisapride—KCNH2—endometrium—ovarian cancer	0.000848	0.0245	CbGeAlD
Cisapride—HTR2B—vagina—ovarian cancer	0.000796	0.023	CbGeAlD
Cisapride—KCNH2—uterus—ovarian cancer	0.000781	0.0225	CbGeAlD
Cisapride—CYP2C8—endometrium—ovarian cancer	0.000776	0.0224	CbGeAlD
Cisapride—HTR2A—embryo—ovarian cancer	0.000775	0.0224	CbGeAlD
Cisapride—CYP3A5—uterine cervix—ovarian cancer	0.000774	0.0223	CbGeAlD
Cisapride—KCNH2—female reproductive system—ovarian cancer	0.000702	0.0203	CbGeAlD
Cisapride—CYP2C19—vagina—ovarian cancer	0.000666	0.0192	CbGeAlD
Cisapride—KCNH2—bone marrow—ovarian cancer	0.000663	0.0191	CbGeAlD
Cisapride—CYP2B6—gonad—ovarian cancer	0.000645	0.0186	CbGeAlD
Cisapride—CYP2C8—female reproductive system—ovarian cancer	0.000643	0.0185	CbGeAlD
Cisapride—KCNH2—female gonad—ovarian cancer	0.000639	0.0184	CbGeAlD
Cisapride—KCNH2—vagina—ovarian cancer	0.000635	0.0183	CbGeAlD
Cisapride—HTR2A—epithelium—ovarian cancer	0.000633	0.0183	CbGeAlD
Cisapride—CYP2C8—vagina—ovarian cancer	0.000581	0.0168	CbGeAlD
Cisapride—CYP2B6—female reproductive system—ovarian cancer	0.000576	0.0166	CbGeAlD
Cisapride—DRD2—testis—ovarian cancer	0.000575	0.0166	CbGeAlD
Cisapride—CYP2C9—female reproductive system—ovarian cancer	0.000571	0.0165	CbGeAlD
Cisapride—KCNH2—testis—ovarian cancer	0.000567	0.0164	CbGeAlD
Cisapride—CYP3A5—female gonad—ovarian cancer	0.000528	0.0152	CbGeAlD
Cisapride—HTR2A—gonad—ovarian cancer	0.000526	0.0152	CbGeAlD
Cisapride—CYP3A5—vagina—ovarian cancer	0.000524	0.0151	CbGeAlD
Cisapride—CYP2B6—vagina—ovarian cancer	0.000521	0.015	CbGeAlD
Cisapride—CYP2C8—testis—ovarian cancer	0.000519	0.015	CbGeAlD
Cisapride—HTR2B—lymph node—ovarian cancer	0.000515	0.0149	CbGeAlD
Cisapride—HTR2A—female reproductive system—ovarian cancer	0.00047	0.0136	CbGeAlD
Cisapride—CYP2B6—testis—ovarian cancer	0.000465	0.0134	CbGeAlD
Cisapride—CYP3A4—female reproductive system—ovarian cancer	0.000435	0.0126	CbGeAlD
Cisapride—CYP2D6—female reproductive system—ovarian cancer	0.000428	0.0124	CbGeAlD
Cisapride—HTR2A—vagina—ovarian cancer	0.000425	0.0123	CbGeAlD
Cisapride—KCNH2—lymph node—ovarian cancer	0.000411	0.0119	CbGeAlD
Cisapride—CYP2D6—female gonad—ovarian cancer	0.00039	0.0112	CbGeAlD
Cisapride—HTR2A—testis—ovarian cancer	0.000379	0.0109	CbGeAlD
Cisapride—CYP2D6—testis—ovarian cancer	0.000346	0.00997	CbGeAlD
Cisapride—HTR2A—Signaling Pathways—TERT—ovarian cancer	9.15e-06	0.000219	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.14e-06	0.000219	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP1B1—ovarian cancer	9.13e-06	0.000218	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—TYMS—ovarian cancer	9.07e-06	0.000217	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	8.88e-06	0.000213	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CG—ovarian cancer	8.88e-06	0.000212	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—APC—ovarian cancer	8.88e-06	0.000212	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—NRAS—ovarian cancer	8.87e-06	0.000212	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.83e-06	0.000211	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—PIK3CA—ovarian cancer	8.7e-06	0.000208	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CAV1—ovarian cancer	8.63e-06	0.000207	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CAV1—ovarian cancer	8.6e-06	0.000206	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CD—ovarian cancer	8.57e-06	0.000205	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—FASN—ovarian cancer	8.56e-06	0.000205	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ERBB2—ovarian cancer	8.54e-06	0.000205	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—MAPK3—ovarian cancer	8.5e-06	0.000204	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CAV1—ovarian cancer	8.46e-06	0.000203	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CAV1—ovarian cancer	8.44e-06	0.000202	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MTOR—ovarian cancer	8.43e-06	0.000202	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CB—ovarian cancer	8.43e-06	0.000202	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SLC5A5—ovarian cancer	8.42e-06	0.000202	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ESR1—ovarian cancer	8.29e-06	0.000198	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ABCB1—ovarian cancer	8.24e-06	0.000197	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	8.16e-06	0.000195	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ESR1—ovarian cancer	8.15e-06	0.000195	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6ST—ovarian cancer	8.15e-06	0.000195	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CB—ovarian cancer	8.15e-06	0.000195	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SLC2A1—ovarian cancer	8.13e-06	0.000195	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—YAP1—ovarian cancer	8.11e-06	0.000194	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CXCL8—ovarian cancer	8.1e-06	0.000194	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—TYMS—ovarian cancer	8.09e-06	0.000194	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	8.09e-06	0.000194	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—MAPK1—ovarian cancer	8.09e-06	0.000194	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—EGFR—ovarian cancer	8.09e-06	0.000194	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.05e-06	0.000193	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HRAS—ovarian cancer	8.05e-06	0.000193	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6ST—ovarian cancer	8.02e-06	0.000192	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.96e-06	0.000191	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CDKN1B—ovarian cancer	7.91e-06	0.000189	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CG—ovarian cancer	7.86e-06	0.000188	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—APC—ovarian cancer	7.83e-06	0.000188	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CG—ovarian cancer	7.83e-06	0.000188	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—NRAS—ovarian cancer	7.83e-06	0.000188	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—AKT1—ovarian cancer	7.83e-06	0.000187	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CD—ovarian cancer	7.8e-06	0.000187	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP1B1—ovarian cancer	7.8e-06	0.000187	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CASP3—ovarian cancer	7.75e-06	0.000186	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL2—ovarian cancer	7.74e-06	0.000185	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—PIK3CA—ovarian cancer	7.73e-06	0.000185	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—APC—ovarian cancer	7.71e-06	0.000185	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CG—ovarian cancer	7.71e-06	0.000185	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—NRAS—ovarian cancer	7.71e-06	0.000185	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—IL6—ovarian cancer	7.7e-06	0.000184	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CG—ovarian cancer	7.68e-06	0.000184	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—KRAS—ovarian cancer	7.64e-06	0.000183	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ABCB1—ovarian cancer	7.58e-06	0.000181	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CCND1—ovarian cancer	7.55e-06	0.000181	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ABCB1—ovarian cancer	7.51e-06	0.00018	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—MAPK3—ovarian cancer	7.5e-06	0.00018	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CTNNB1—ovarian cancer	7.47e-06	0.000179	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CB—ovarian cancer	7.47e-06	0.000179	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—TYMS—ovarian cancer	7.44e-06	0.000178	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK3—ovarian cancer	7.38e-06	0.000177	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—TYMS—ovarian cancer	7.38e-06	0.000177	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MMP9—ovarian cancer	7.33e-06	0.000175	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CAV1—ovarian cancer	7.31e-06	0.000175	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PTEN—ovarian cancer	7.28e-06	0.000174	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—MAPK1—ovarian cancer	7.14e-06	0.000171	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—EGFR—ovarian cancer	7.14e-06	0.000171	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—AKT1—ovarian cancer	7.11e-06	0.00017	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTEN—ovarian cancer	7.04e-06	0.000169	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK1—ovarian cancer	7.02e-06	0.000168	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—EGFR—ovarian cancer	7.02e-06	0.000168	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PIK3CA—ovarian cancer	7.02e-06	0.000168	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.98e-06	0.000167	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	6.92e-06	0.000166	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CD—ovarian cancer	6.91e-06	0.000165	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ERBB2—ovarian cancer	6.89e-06	0.000165	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CD—ovarian cancer	6.89e-06	0.000165	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.88e-06	0.000165	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PIK3CA—ovarian cancer	6.82e-06	0.000163	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MTOR—ovarian cancer	6.8e-06	0.000163	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CB—ovarian cancer	6.8e-06	0.000163	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CD—ovarian cancer	6.78e-06	0.000162	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CD—ovarian cancer	6.76e-06	0.000162	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—KRAS—ovarian cancer	6.74e-06	0.000161	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PIK3CA—ovarian cancer	6.71e-06	0.000161	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CG—ovarian cancer	6.66e-06	0.000159	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—KRAS—ovarian cancer	6.63e-06	0.000159	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—FASN—ovarian cancer	6.61e-06	0.000158	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—ovarian cancer	6.58e-06	0.000158	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CXCL8—ovarian cancer	6.54e-06	0.000156	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CAV1—ovarian cancer	6.52e-06	0.000156	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—STAT3—ovarian cancer	6.51e-06	0.000156	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.5e-06	0.000156	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NRAS—ovarian cancer	6.5e-06	0.000156	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HRAS—ovarian cancer	6.49e-06	0.000155	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTEN—ovarian cancer	6.45e-06	0.000154	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ABCB1—ovarian cancer	6.42e-06	0.000154	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDKN1B—ovarian cancer	6.38e-06	0.000153	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—ovarian cancer	6.31e-06	0.000151	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—TYMS—ovarian cancer	6.31e-06	0.000151	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC2A1—ovarian cancer	6.28e-06	0.00015	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CASP3—ovarian cancer	6.25e-06	0.00015	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL2—ovarian cancer	6.25e-06	0.00015	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.23e-06	0.000149	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK3—ovarian cancer	6.22e-06	0.000149	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL6—ovarian cancer	6.21e-06	0.000149	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PIK3CA—ovarian cancer	6.19e-06	0.000148	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PIK3CA—ovarian cancer	6.09e-06	0.000146	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCND1—ovarian cancer	6.09e-06	0.000146	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ERBB2—ovarian cancer	6.08e-06	0.000146	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MYC—ovarian cancer	6.05e-06	0.000145	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CTNNB1—ovarian cancer	6.03e-06	0.000144	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CB—ovarian cancer	6.02e-06	0.000144	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.02e-06	0.000144	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MTOR—ovarian cancer	6e-06	0.000144	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CB—ovarian cancer	6e-06	0.000144	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CAV1—ovarian cancer	6e-06	0.000144	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ERBB2—ovarian cancer	5.98e-06	0.000143	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CAV1—ovarian cancer	5.95e-06	0.000142	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CG—ovarian cancer	5.94e-06	0.000142	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK1—ovarian cancer	5.92e-06	0.000142	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EGFR—ovarian cancer	5.92e-06	0.000142	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MMP9—ovarian cancer	5.91e-06	0.000142	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CB—ovarian cancer	5.91e-06	0.000141	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MTOR—ovarian cancer	5.91e-06	0.000141	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CB—ovarian cancer	5.89e-06	0.000141	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PTEN—ovarian cancer	5.88e-06	0.000141	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CD—ovarian cancer	5.85e-06	0.00014	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CXCL8—ovarian cancer	5.77e-06	0.000138	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—ovarian cancer	5.73e-06	0.000137	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HRAS—ovarian cancer	5.73e-06	0.000137	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.68e-06	0.000136	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CXCL8—ovarian cancer	5.67e-06	0.000136	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HRAS—ovarian cancer	5.64e-06	0.000135	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	5.63e-06	0.000135	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KRAS—ovarian cancer	5.59e-06	0.000134	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	5.57e-06	0.000133	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	5.54e-06	0.000133	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CASP3—ovarian cancer	5.52e-06	0.000132	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL2—ovarian cancer	5.51e-06	0.000132	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL6—ovarian cancer	5.48e-06	0.000131	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	5.48e-06	0.000131	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CG—ovarian cancer	5.46e-06	0.000131	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CASP3—ovarian cancer	5.43e-06	0.00013	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL2—ovarian cancer	5.42e-06	0.00013	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.42e-06	0.00013	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL6—ovarian cancer	5.4e-06	0.000129	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCND1—ovarian cancer	5.37e-06	0.000129	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.34e-06	0.000128	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	5.32e-06	0.000127	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—ovarian cancer	5.31e-06	0.000127	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCND1—ovarian cancer	5.29e-06	0.000127	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STAT3—ovarian cancer	5.26e-06	0.000126	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NRAS—ovarian cancer	5.24e-06	0.000126	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	5.24e-06	0.000125	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CD—ovarian cancer	5.22e-06	0.000125	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MMP9—ovarian cancer	5.22e-06	0.000125	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTEN—ovarian cancer	5.21e-06	0.000125	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PTEN—ovarian cancer	5.19e-06	0.000124	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CA—ovarian cancer	5.14e-06	0.000123	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MMP9—ovarian cancer	5.13e-06	0.000123	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PTEN—ovarian cancer	5.1e-06	0.000122	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CB—ovarian cancer	5.1e-06	0.000122	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTEN—ovarian cancer	5.09e-06	0.000122	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CAV1—ovarian cancer	5.08e-06	0.000122	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—ovarian cancer	5.06e-06	0.000121	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	5.02e-06	0.00012	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	4.98e-06	0.000119	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—ovarian cancer	4.97e-06	0.000119	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CA—ovarian cancer	4.97e-06	0.000119	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.96e-06	0.000119	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MYC—ovarian cancer	4.88e-06	0.000117	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—TYMS—ovarian cancer	4.87e-06	0.000117	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.86e-06	0.000116	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CD—ovarian cancer	4.8e-06	0.000115	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	4.78e-06	0.000114	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGFR—ovarian cancer	4.78e-06	0.000114	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.76e-06	0.000114	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HRAS—ovarian cancer	4.75e-06	0.000114	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—ovarian cancer	4.68e-06	0.000112	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STAT3—ovarian cancer	4.64e-06	0.000111	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.63e-06	0.000111	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NRAS—ovarian cancer	4.63e-06	0.000111	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	4.61e-06	0.00011	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STAT3—ovarian cancer	4.56e-06	0.000109	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NRAS—ovarian cancer	4.55e-06	0.000109	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.55e-06	0.000109	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CA—ovarian cancer	4.55e-06	0.000109	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL6—ovarian cancer	4.55e-06	0.000109	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KRAS—ovarian cancer	4.51e-06	0.000108	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK3—ovarian cancer	4.43e-06	0.000106	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTEN—ovarian cancer	4.41e-06	0.000106	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	4.36e-06	0.000104	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MYC—ovarian cancer	4.31e-06	0.000103	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MYC—ovarian cancer	4.24e-06	0.000102	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK1—ovarian cancer	4.22e-06	0.000101	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGFR—ovarian cancer	4.22e-06	0.000101	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—ovarian cancer	4.2e-06	0.000101	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.19e-06	0.0001	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CB—ovarian cancer	4.15e-06	9.94e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	4.15e-06	9.93e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGFR—ovarian cancer	4.15e-06	9.93e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	4.15e-06	9.93e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.07e-06	9.74e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—ovarian cancer	4.06e-06	9.71e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—ovarian cancer	4.01e-06	9.6e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KRAS—ovarian cancer	3.98e-06	9.53e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTEN—ovarian cancer	3.93e-06	9.42e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CAV1—ovarian cancer	3.92e-06	9.39e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KRAS—ovarian cancer	3.92e-06	9.38e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HRAS—ovarian cancer	3.84e-06	9.18e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—ovarian cancer	3.72e-06	8.9e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CA—ovarian cancer	3.67e-06	8.79e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL6—ovarian cancer	3.67e-06	8.79e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	3.66e-06	8.76e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTEN—ovarian cancer	3.62e-06	8.66e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	3.6e-06	8.62e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.59e-06	8.59e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTEN—ovarian cancer	3.59e-06	8.59e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.57e-06	8.55e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.55e-06	8.49e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—ovarian cancer	3.54e-06	8.47e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—ovarian cancer	3.48e-06	8.34e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—ovarian cancer	3.39e-06	8.11e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HRAS—ovarian cancer	3.38e-06	8.1e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HRAS—ovarian cancer	3.33e-06	7.97e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6—ovarian cancer	3.24e-06	7.76e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6—ovarian cancer	3.19e-06	7.63e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.14e-06	7.52e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CA—ovarian cancer	3.11e-06	7.44e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTEN—ovarian cancer	3.06e-06	7.34e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—ovarian cancer	3e-06	7.18e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—ovarian cancer	2.99e-06	7.16e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—ovarian cancer	2.94e-06	7.04e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—ovarian cancer	2.93e-06	7.02e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.77e-06	6.64e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.74e-06	6.55e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.55e-06	6.11e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—ovarian cancer	2.54e-06	6.08e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.53e-06	6.06e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTEN—ovarian cancer	2.37e-06	5.66e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—ovarian cancer	2.27e-06	5.43e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.16e-06	5.18e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—ovarian cancer	2.09e-06	4.99e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—ovarian cancer	2.07e-06	4.95e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—ovarian cancer	1.77e-06	4.23e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.67e-06	4e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—ovarian cancer	1.36e-06	3.26e-05	CbGpPWpGaD
